Cambridge Nucleomics is a biotech spinoff from the University of Cambridge. We help big pharmas, biotech companies and clinical researchers with a unique value proposition for accurate, fast and direct quantification of native RNA. Our mission is to quantify all short and long RNAs in one simple measurement by 2025, with the vision to build an innovative platform technology company for the RNA era of personalised and precision medicine.
Get in touch
News about Cambridge Nucleomics
Research centre news
Entrepreneurship Centre startups finalists in 2024 Science & Tech awards
Many alumni and startups of Cambridge Judge Entrepreneurship Centre programmes have been named finalists in the Cambridge Independent Science and Technology Awards 2024.
Student and alumni news
Cambridge Judge Entrepreneurship Centre alums win 2024 Trinity Bradfield Prizes
3 biotech businesses founded by alumni of Cambridge Judge Entrepreneurship Centre programmes have been awarded the top three spots at the prestigious Trinity Bradfield Prize competition run by the Bradfield Centre and Trinity College, University of Cambridge.